000 | 01984 a2200517 4500 | ||
---|---|---|---|
005 | 20250516025608.0 | ||
264 | 0 | _c20120608 | |
008 | 201206s 0 0 eng d | ||
022 | _a1433-7339 | ||
024 | 7 |
_a10.1007/s00520-011-1127-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTofthagen, Cindy | |
245 | 0 | 0 |
_aFalls in persons with chemotherapy-induced peripheral neuropathy. _h[electronic resource] |
260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cMar 2012 |
||
300 |
_a583-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAccidental Falls _xstatistics & numerical data |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aCausality |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscle Weakness _xchemically induced |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms _xclassification |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 | _aPopulation Surveillance |
650 | 0 | 4 | _aPostural Balance |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSensation Disorders _xchemically induced |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
700 | 1 | _aOvercash, Janine | |
700 | 1 | _aKip, Kevin | |
773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 20 _gno. 3 _gp. 583-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-011-1127-7 _zAvailable from publisher's website |
999 |
_c20653274 _d20653274 |